Scott Guenthner

941 citations

22 papers · 317 indexed · h-index 8

Impact in

Dermatology top 2%
- Dermatology and Skin Diseases
- Cancer and Skin Lesions
- Cutaneous lymphoproliferative disorders research
Immunology
- Psoriasis: Treatment and Pathogenesis

Papers in ⓘ

Dermatology 7
- Dermatology and Skin Diseases 4
- Skin Protection and Aging 3
Epidemiology 7
- Nonmelanoma Skin Cancer Studies 4
- Nail Diseases and Treatments 3

Co-authors: Robert Hurwitz (1 shared paper)Howard R. Gray (1 shared paper)Mark Lebwohl (4 shared papers)Kim Papp (3 shared papers)Anna M. Tallman (3 shared papers)Hwanhee Hong (2 shared papers)Leon Kircik (4 shared papers)Linda Stein Gold (3 shared papers)
Journals: Journal of the American Academy of Dermatology (6 papers)Clinical and Experimental Dermatology (2 papers)Dermatology and Therapy (2 papers)American Journal of Clinical Dermatology (2 papers)Journal of Drugs in Dermatology (1 paper)
Partner nations: United States Canada Australia

In The Last Decade

Scott Guenthner

20 papers receiving 312 citations

Peers

Countries citing papers authored by Scott Guenthner

Since Specialization

Citations

This map shows the geographic impact of Scott Guenthner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Guenthner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Guenthner more than expected).

Fields of papers citing papers by Scott Guenthner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Guenthner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Guenthner. The network helps show where Scott Guenthner may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott Guenthner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Guenthner Line = papers co-authored together Scott Guenthner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis New England Journal of Medicine ·Mark Lebwohl, Linda Stein Gold, Bruce Strober, Kim Papp, April W. Armstrong, Jerry Bagel, Leon Kircik, Benjamin D. Ehst, Hwanhee Hong, Jennifer Soung, Jeff Fromowitz, Scott Guenthner, Stephen C. Piscitelli, David S. Rubenstein, Philip M. Brown, Anna M. Tallman, Robert Bissonnette	2021	125
2	Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: A clinicopathologic correlation Journal of the American Academy of Dermatology ·Scott Guenthner, Robert Hurwitz, Larry J. Buckel, Howard R. Gray	1999	64
3	Health care resource use, productivity, and costs among patients with moderate to severe plaque psoriasis in the United States Journal of the American Academy of Dermatology ·Caroline Schaefer, Joseph C. Cappelleri, Rebecca Cheng, Jason C. Cole, Scott Guenthner, Joseph F. Fowler, Sandy Johnson, Carla Mamolo	2015	43
4	Efficacy, Safety, and Patient-Reported Outcomes in Patients with Moderate-to-Severe Plaque Psoriasis Treated with Brodalumab for 5 Years in a Long-Term, Open-Label, Phase II Study American Journal of Clinical Dermatology ·Mark Lebwohl, Andrew Blauvelt, Alan Menter, Kim Papp, Scott Guenthner, Radhakrishnan Pillai, Robert J. Israel, Abby Jacobson	2019	30
5	Real-world assessment and treatment of locally advanced basal cell carcinoma: Findings from the RegiSONIC disease registry PLoS ONE ·Aleksandar Sekulić, Simon Yoo, Ragini R. Kudchadkar, Julie Guillen, Gary S. Rogers, Anne Lynn S. Chang, Scott Guenthner, Bernard I. Raskin, Keith Dawson, Yong Mun, Laura Chu, Edward McKenna, Mario E. Lacouture	2022	11
6	A skin cancer education initiative at a professional baseball game and results of a skin cancer survey International Journal of Dermatology ·Emily Ann Jungers, Scott Guenthner, Evan R. Farmer, Susan M. Perkins	2003	10
7	The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosis Journal of the American Academy of Dermatology ·Joyce Teng, Christopher G. Bunick, Scott Guenthner, Dédée F. Murrell, Kalyani Marathe, Steven Kempers, Kimmie Eads, Alan M. Mendelsohn, Jessica Raiz, Amir Tavakkol, Leslie Castelo‐Soccio	2022	7
8	Tapinarof Cream 1% QD for the Treatment of Plaque Psoriasis: Efficacy and Safety in Two Pivotal Phase 3 Trials SKIN The Journal of Cutaneous Medicine ·Mark Lebwohl, Linda Stein Gold, Bruce Strober, April W. Armstrong, Hwanhee Hong, Leon Kircik, Jennifer Soung, Jeff Fromowitz, Scott Guenthner, Stephen C. Piscitelli, David S. Rubenstein, Philip Brown, Anna M. Tallman, Robert Bissonnette	2020	7
9	Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosis Clinical and Experimental Dermatology ·Dédée F. Murrell, Joyce Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Leslie Castelo‐Soccio, Alan M. Mendelsohn, Jessica Raiz, Christopher G. Bunick	2023	5
10	The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Atopic Dermatitis: Phase 2 Proof-of-Concept Study SKIN The Journal of Cutaneous Medicine ·Melinda Gooderham, Leon Kircik, Matthew Zirwas, Mark Lee, Steven Kempers, Zoé Kececioglu Draelos, Laura K. Ferris, Terry M. Jones, Étienne Saint‐Cyr Proulx, Robert Bissonnette, Neal Bhatia, Scott Guenthner, Robert A. Koppel, Howard G. Welgus, Charlotte Merritt, M.E.M. Elias, Lynn Navale, Robert Higham, Michael Droege, David R. Berk	2020	4
11	Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL Study Dermatology and Therapy ·Kalyani Marathe, Joyce Teng, Scott Guenthner, Christopher G. Bunick, Steven Kempers, Kimmie Eads, Leslie Castelo‐Soccio, Alan M. Mendelsohn, Jessica Raiz, Dédée F. Murrell	2023	2
12	Inter- and Intra-Physician Variation in Quantifying Actinic Keratosis Skin Photodamage PubMed ·Benjamin N. Schmeusser, Christina E. Borchers, Jeffrey B. Travers, Samia W. Borchers, Julian Trevino, Max B. Rubin, HEIDI B. DONNELLY, J. Mikhail Kellawan, Lydia Carpenter, Shalini Bahl, Craig A. Rohan, Elizabeth Muennich, Scott Guenthner, Holly Hahn, Ali M. Rkein, Marc Darst, Nico Mousdicas, Elizabeth Cates, Ulaş Sunar, Trevor Bihl	2020	1
13	Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts American Journal of Clinical Dermatology ·Scott Guenthner, Wendy McFalda, M. Quinn Tate, Kimberly Eads, Jayson Rieger, David K. Glover, Cynthia J. Willson, Pamela Rumney, Ted Rosén, Jennifer Andres, Melissa Olivadoti	2021	1
14	COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts Dermatology and Therapy ·Scott Guenthner, Wendy McFalda, Pearl Kwong, Kimberly Eads, Morgan McCafferty, Jayson Rieger, David K. Glover, Cynthia J. Willson, Patrick Burnett, Melissa Olivadoti	2021	1
15	Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL study Clinical and Experimental Dermatology ·Christopher G. Bunick, Joyce Teng, Scott Guenthner, Kalyani Marathe, Steven Kempers, Kimmie Eads, Leslie Castelo‐Soccio, Alan M. Mendelsohn, Jessica Raiz, Dédée F. Murrell	2023	1
16	Efficacy of Tapinarof Cream 1% Once Daily for the Treatment of Mild to Severe Intertriginous Plaque Psoriasis SKIN The Journal of Cutaneous Medicine ·Howard Sofen, Stephen K. Tyring, Sandra Marchese Johnson, Scott Guenthner, Patrick Shannon, Philip M. Brown, Katherine Tillman, Nancy Fitzgerald, Brandon Kirsch, Anna M. Tallman	2023	1
17	31865 Pooled efficacy and safety results from the DERMIS-1 and DERMIS-2 phase 3 trials of once-daily roflumilast cream 0.3% for treatment of chronic plaque psoriasis Journal of the American Academy of Dermatology ·Mark Lebwohl, J Melinda, Scott Guenthner	2022	1
18	Exposure–Response Analysis Demonstrates Response to Tapinarof is Driven by Local Effects at Sites of Application SKIN The Journal of Cutaneous Medicine ·J.Q. Del Rosso, Scott Guenthner, Chih-ho Hong, John E Jett, Philip M. Brown, David S. Rubenstein, Stephen C. Piscitelli	2022	1
19	Halobetasol Propionate Lotion 0.01% for Moderate-to-Severe Plaque Psoriasis: Pooled Analysis in Male and Female Participants Journal of Drugs in Dermatology ·Fran Cook-Bolden, Adelaide Hebert, Scott Guenthner, Robert Kang, Gina Martin, Abby Jacobson	2020	1
20	15904 Efficacy and safety of long-term tildrakizumab for plaque psoriasis: 4-year results from reSURFACE 1 Journal of the American Academy of Dermatology ·Jeffrey Crowley, Neil J. Korman, Lynda Spelman, Atsuyuki Igarashi, Aditya K. Gupta, Alan M. Mendelsohn, Stephen J. Rozzo, Kimberly Eads, Scott Guenthner	2020	1

About Scott Guenthner

Scott Guenthner is a scholar working on Dermatology, Epidemiology, Immunology, Pathology and Forensic Medicine and Cell Biology, having authored 22 papers that have together received 317 indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (6 papers), Dermatology and Skin Diseases (4 papers), Skin and Cellular Biology Research (4 papers), Nonmelanoma Skin Cancer Studies (4 papers), Cutaneous Melanoma Detection and Management (3 papers), Skin Protection and Aging (3 papers), melanin and skin pigmentation (3 papers) and Nail Diseases and Treatments (3 papers). The work is most often cited by research in Dermatology (202 citations), Immunology (161 citations), Immunology and Allergy (29 citations), Epidemiology (75 citations) and Family Practice (4 citations). Scott Guenthner has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert Hurwitz, Howard R. Gray, Mark Lebwohl, Kim Papp, Anna M. Tallman, Hwanhee Hong, Leon Kircik, Linda Stein Gold, Bruce Strober and Jennifer Soung. Their work appears in journals such as Journal of the American Academy of Dermatology, Clinical and Experimental Dermatology, Dermatology and Therapy, American Journal of Clinical Dermatology and Journal of Drugs in Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact